North Country Senator Joseph Griffo R-Rome says the U.S. Food and Drug Administration’s looming guidelines requiring restaurants to list nutritional values of the beers it sells could threaten the success of New York’s smaller craft breweries.

In St. Lawrence County, St. Lawrence Brewing in Canton could be affected if the guidelines take effect next December as planned.

But any further growth of New York’s $3.5 billion craft beer industry could be stifled by the guidelines, Griffo’s stated in a letter to the U.S. Food and Drug Administration.

Griffo represents the 47th Senate District. It includes a swath running through the middle of St. Lawrence County, from Massena to Fine, including Potsdam.

With some smaller breweries potentially unable to afford the costly nutritional tests to analyze a particular beer, some restaurants may limit the variety of beers they offer or some breweries may be forced to discontinue certain seasonal brands in order to ensure their other beers are sold.

In order to ensure that craft breweries across New York are able compete in the larger beer market, Griffo strongly urged the FDA to reconsider this troubling mandate.

“The federal guidelines, as stated by the FDA, will put smaller craft breweries at a great disadvantage while offering very little redeeming value, right at a time when this industry is experiencing healthy economic momentum,” Griffo wrote.

Sen. Griffo also sent the letter to federal legislators in hopes of their intervention.

The letter from Griffo is as follows:

“Dear Acting Commissioner Ostroff:

I would like to express my concerns regarding the FDA-issued guidelines that will soon require chain restaurants and other food service establishments to provide full nutritional information for all beers listed on their menus.

I believe these guidelines would have a particularly negative impact on smaller craft breweries, and I urge the FDA to reconsider this troubling mandate.

In New York State, we have taken significant steps to help foster and strengthen small businesses in the craft beer industry. As a result, by 2013 the craft beer sector had blossomed into a $3.5 billion statewide industry with more than 200 breweries in operation, more than 11,000 full-time jobs with $554 million in paid wages, $277 million in brewery revenue, $748 million in state and local taxes and $450 million raised through craft beer tourism.

The FDA’s impending guidelines could stifle all the economic growth that New York State has accomplished over the years in developing its burgeoning craft beer industry. Not only will it become extremely costly for smaller breweries to fulfill these requirements, but it could also undercut healthy competition among beer breweries and limit the variety of beers available at various establishments.

The consequences could be far-reaching: Because it can cost $600 or more for breweries to analyze a particular brew of beer for its caloric value, some craft breweries may have to limit what beers they offer to restaurants for widespread distribution. This expense may also force some breweries to discontinue certain seasonal beers that patrons have come to enjoy. If certain restaurants or food service establishments refuse to sell a particular beer because the brewery cannot afford to test its nutritional value, that could prevent those breweries from ever breaking into a larger market to compete against bigger beer brands. Instead of allowing competition to thrive, these guidelines could instead favor the larger breweries that can afford these new costs.

I have a number of breweries in my district, and I know their passionate owners are trying their best to grow like any other business and offer a quality product that people want to buy. And, it should be noted that the caloric or nutritional value of a particular beer is often of little concern to anyone who favors these types of beverages – what often matters most is variety, and taste.

The federal guidelines, as stated by the FDA, will put smaller craft breweries at a great disadvantage while offering very little redeeming value, right at a time when this industry is experiencing healthy economic momentum. I strongly encourage you to reconsider these guidelines.”